- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06177782
Accuracy of Tooth Modified Scan Bodies as a Novel Technique
December 11, 2023 updated by: Doaa Adel Salah Khattab, Ain Shams University
Accuracy of Tooth Modified Scan Bodies as a Novel Technique for Edentulous Full Arch Implant Supported Dental Prosthesis: A Controlled Clinical Trial
The clinical performance of a novel scan body Tooth Modified Scan Body (TMSB) in the degree of trueness of IOS impression for full arch cases.
I
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The clinical performance of a novel scan body Tooth Modified Scan Body (TMSB) in the degree of trueness of IOS impression for full arch cases.
TMSB is a scan body to which different teeth are attached directly as one piece, this may enhance the accuracy level by filling the gabs between ISB as well as acting as a stable artificial AI-easily recognized landmarks thus facilitating the scanning procedure.
OS impression utilizing tooth modified scan bodies or conventional scan bodies result in the same degree of trueness as conventional verified splinted open tray impression.
To our knowledge, it is the first time in the literature to utilize a novel scan body modified with directly connected teeth as artificial landmarks in vivo.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Abbassia
-
Cairo, Abbassia, Egypt, 11566
- ain shams University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Participants who had received 4-6 implants in 1 edentulous arch.
- Participants with 1-piece implant-supported complete-arch fixed dental prostheses.
- Systemically free.
- Primary implant stability exceed 72 the day of the definitive impression.
Exclusion Criteria:
- Smoker's.
- Non co-operative patients.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Tooth Modified Scan Bodies
The intraoral scanner (IOS) impression will be recorded using modified scan bodies.
The IOS device will be calibrated right before the impression.
The scan strategy will be consistent for all the procedures following the manufacturer guidelines.
|
Tooth modified scan bodies are used during scanning for full arch implant cases.
|
Placebo Comparator: Conventional Scan Bodies
The intraoral scanner (IOS) impression will be recorded using conventional implant scan bodies secured at the multiunit abutment level.
|
Conventional scan bodies will be used for scanning the full arch implant cases.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of trueness
Time Frame: Immediately postoperative
|
Digital files will be obtained: either conventional scan or TMSB scan.
All the STL files will be imported to dental CAD software , and scan bodies will be converted to implant multi-unit ti-base replicas using a digital library.
Then, updated STL files will be imported to inspection software for trueness assessments.
|
Immediately postoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 10, 2023
Primary Completion (Actual)
October 18, 2023
Study Completion (Actual)
November 20, 2023
Study Registration Dates
First Submitted
December 11, 2023
First Submitted That Met QC Criteria
December 11, 2023
First Posted (Estimated)
December 20, 2023
Study Record Updates
Last Update Posted (Estimated)
December 20, 2023
Last Update Submitted That Met QC Criteria
December 11, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 22859
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Digital Technology
-
Universitaire Ziekenhuizen KU LeuvenOslo University Hospital; University of Bordeaux; KU Leuven; University College... and other collaboratorsNot yet recruitingGeriatrics | Medical Oncology | Critical Pathways | Digital TechnologyBelgium
-
Ain Shams UniversityAssiut UniversityCompletedDental Implant | Occlusion | Digital TechnologyEgypt
-
Implantology InstituteNot yet recruitingProsthesis User | Occlusion | Lip | Digital Technology | Oral Soft Tissue ConditionsPortugal
-
Aslı MemisNot yet recruitingAdolescent | Behavior, Addictive | Motivation | Digital TechnologyTurkey
-
University of BrightonNord University; Brighton & Hove Digital Health Living LabNot yet recruitingHealthy Aging | Old Age; Debility | Dignity | Digital TechnologyUnited Kingdom
-
University of New BrunswickMcGill University; McMaster University; University of Ottawa; Alzheimer Society... and other collaboratorsCompletedDementia | Caregiver Burden | Mental Health | Psychotherapy | Acceptance and Commitment Therapy | Technology | Digital Health | CounsellingCanada
-
University Hospital, Clermont-FerrandNot yet recruitingExercise | Sedentary Behavior | Multimorbidity | Comorbidities and Coexisting Conditions | Digital Technology | Comorbidity | Non Communicable DiseasesFrance
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...CompletedTechnologyHong Kong
Clinical Trials on Tooth modified scan bodies
-
Ain Shams UniversityActive, not recruiting
-
Prince of Songkla UniversityCompleted
-
University College, LondonWithdrawnPost-menopausal OsteoporosisUnited Kingdom
-
Dr Andrew OdurUganda Martyrs University, St. Francis Hospital Nsambya, Jerusalem IHS and...CompletedPerinatal Death | Third Trimester Modified Biophysical Profile ScanUganda
-
Semmelweis UniversityRecruitingOdontogenic CystsHungary
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, Germany, Spain, United Kingdom, Japan, Turkey
-
BioMarin PharmaceuticalActive, not recruitingAchondroplasiaUnited States, Australia, France, United Kingdom
-
Charite University, Berlin, GermanyCompletedHealthy | Alcohol Use Disorder (Mild vs. Moderate to Heavy)Germany
-
National Cancer Institute (NCI)NRG OncologyRecruitingAnatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast CarcinomaUnited States, Puerto Rico
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | High Grade B-Cell Non-Hodgkin's Lymphoma | Intermediate Grade B-Cell Non-Hodgkin's LymphomaUnited States